DNA microarrays are a powerful tool for monitoring thousands of transcript levels simultaneously. However, the use of DNA microarrays in studying the central nervous system faces several challenges. These include the detection of low-abundance
Introduction
DNA microarrays are used to measure the relative expression levels of thousands of transcripts to enable global analysis of biological systems and have lead to important discoveries, described in several reviews, in the ®elds of cancer (Clarke et al., 2001) , pathology (KatoMaeda et al., 2001) , antimicrobial drug discovery (Ivanov et al., 2000) and neuroscience (Cao & Dulac, 2001) . However, the limits of DNA microarray technology have not been well described and the use of DNA microarrays to study the brain faces signi®cant challenges with regard to sensitivity, largely because of the high complexity of neuronal tissue.
Estimates have been made to predict the limit of sensitivity of DNA microarrays. Speci®cally, Affymetrix, who manufacture Gene Chips Ð a form of DNA microarrays, reports that Gene Chips can reliably detect cRNA species in a hybridization cocktail at » 2 pM. Using a homogenous cell population as the source of RNA this would translate to » 1 copy per cell. However, this has little value in determining the limits of detection of microarray technology in complex tissue, like brain structures, where there are a large number of specialized cells with variant transcriptional pro®les. Many transcripts that are important for brain function are expressed at low levels or in a relatively small number of cells. For example, gonadotropin-releasing hormone (GnRH), which is imperative to reproductive function, is only expressed in a few thousand cells (Yellon et al., 1990) dispersed throughout the hypothalamus (King et al., 1984) . Analysis of hypothalamic RNA by Affymetrix U34A Gene Chips only detects this transcript » 50% of the time when using a gross hypothalamic dissection as the source tissue (our unpublished data). This insensitivity presents signi®cant problems in successfully monitoring expression level variations in response to experimental manipulation of many biologically relevant transcripts.
Techniques to reduce tissue complexity, such as microdissection or laser-capture microscopy (Emmert-Buck et al., 1996) , are likely to improve the detection of cell-speci®c transcripts by DNA microarrays. These types of focused studies may indeed be the most appropriate at times but in many cases speci®c cellular nuclei important to a given experimental paradigm will not have been identi®ed or the study of too many speci®c neuroanatomical areas by microarray may not be feasible. Typically, successful DNA microarray studies in brain have focused on discrete structures followed by the use of anatomical techniques, such as in situ hybridization (Mirnics et al., 2000; Sandberg et al., 2000; Mody et al., 2001; Zhao et al., 2001; Zirlinger et al., 2001) .
Serial analysis of gene expression (SAGE) is a high-throughput sequencing-based technique used to estimate the relative expression levels of thousands of transcripts by sequencing concatamers of short sequence tags derived from a biological sample (Velculescu et al., 1995) . The relative abundance of transcripts in the sample can be estimated because it is proportional to the representation of the transcripts by sequence tags in the SAGE data. This technique has previously been used by Datson et al. (2001) to analyse the transcriptome of the rat hippocampus, which is a complex heterogenous tissue composed of several morphologically distinct neuronal and non-neuronal cell types. In this study, in which a total of 76 790 SAGE tags were analysed, the number of low-abundance transcripts was shown to be far greater than the number of high-abundance transcripts. In fact, transcripts of low abundance, detectable with 1±5 SAGE tags each in this study, represented 80% of the total number of unique tags. Transcripts of intermediate abundance, with 6±50 tags, represented 19% of the unique tags, while high-abundance transcripts with > 50 tags represented only 1% of total unique tags detected. Furthermore, annotation of transcripts in this study, to reveal distribution of functional gene families with regard to expression level, found that most genes contributing to functional specialization of neuronal tissue are of relatively low abundance. For example, neurotransmitter receptors, ion channels, synaptic components, signal transduction machinery and transcription factors were generally represented by few SAGE tags.
In the current study we have evaluated the ef®ciency of detection of hippocampal transcripts by Affymetrix RG-U34A Gene Chips using expression level estimates obtained by SAGE. Using this analysis we were able to estimate the percentage of transcripts being reliably detected by Gene Chips across various expression levels and functional classes. This report provides the ®rst broad analysis of the sensitivity of DNA microarray technology in the complex background of neuronal tissue.
Methods

Animals and tissue preparation
Male Sprague-Dawley rats from Charles River (Wilmington, MA, USA), weighing 250±300 g, were used in this study. They were housed three per cage in 43 Q 21.5 Q 25.5 cm plexiglass cages, and kept on a 12-h light±dark cycle (lights off at 07.00 h). Food and water were available ad libitum. All experiments were conducted in accordance with the guidelines of the animal ethics committee at the University of Michigan following the Guide for the Care and Use of Laboratory Animals (National Research Council 1996) . After 2 weeks of habituation to the housing conditions, the rats were killed by decapitation between 11.00 and 13.00 h. The brains were immediately removed, and hippocampi rapidly dissected and frozen. Tissues were stored at ±80°C until total RNA extraction.
Gene Chip studies
In total, 43 Affymetrix RG-U34A Gene Chips were hybridized with cRNA derived from individual hippocampi from Sprague-Dawley rats so that each Gene Chip represented the hippocampus of one rat. Total RNA was extracted separately from individual hippocampi using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) per manufacturers instructions followed by a cleanup step using RNeasy RNA puri®cation columns (Qiagen, Valencia, CA, USA). Using 10 mg total RNA as determined by absorbance at 260 nm, ®rst and second strand synthesis was performed per instructions in the Affymetrix Expression Analysis Technical Manual, ver3 (Affymetrix, Santa Clara, CA, USA). cRNA was synthesized using the Bioarray High Yield RNA Transcript Labeling Kit (Enzo, New York, NY, USA) and prepared for hybridization with RG-U34A Gene Chips per Affymetrix instructions. Gene Chips were hybridized for 18 h at 42°C, washed and stained on an Affymetrix¯uidics station using the standard EukGEws2v3 protocol and scanned with a Gene Array Scanner. Raw image data were quanti®ed with Affymetrix MAS 5.0 using all default threshold settings.
SAGE studies
SAGE data was derived from the results of the study by Datson et al. using hippocampi from male Wistar rats (Datson et al., 2001) . Unique accession numbers from SAGE data were merged with Affymetrix Gene Chip probe set identi®ers using ProbeMatchDB (Wang et al., 2002) .
Results
The results described below are derived from 1000 transcripts that could be evaluated because they were unambiguous and common to the SAGE and Gene Chip data sets. These are all of the transcripts with a SAGE tag that was uniquely identi®ed by a single GenBank accession number and was mapped to a single UniGene cluster (build no. 96) that was represented on the RG-U34A array. This set of 1000 transcripts had a distribution through the various SAGE tag bins similar to those described in the original SAGE study (Datson et al., 2001) and is therefore assumed to be representative for the purpose of the current study. Figure 1a shows the overall detection ef®ciencies by Affymetrix Gene Chips of the 1000 hippocampal transcripts. This ®gure illustrates that Affymetrix Gene Chips reliably detect 41% and are unable to detect 17% of these transcripts across all 43 Gene Chips used in this study. The remaining 42% of transcripts are detected somewhere between 0 and 100% of the time, as further detailed in the ®gure. Detection is de®ned as receiving a`present' or`marginal' call from the Affymetrix MAS 5.0 software using the default settings, which would identify any transcripts with a detection P-value of 0.06. The average detection P-values (across all 43 Gene Chips) for the various bins detailed in the ®gure were 0.548, 0.285, 0.172, 0.070, 0.022 and 0.002 for the detection bins of 0, 1±25, 26±50, 51± 75, 76±99 and 100%, respectively. Figure 1b shows the detection ef®ciency by Gene Chips of the 1000 unique transcripts relative to their abundance bins as described by SAGE. These results show that the low-abundance transcripts, represented by a single SAGE tag, were detected an average of 55% of the time and that high-abundance transcripts, represented by > 50 SAGE tags, were detected an average of 90% of the time on Affymetrix U34A arrays. Transcripts of intermediate abundance with 2±5, 6±10 and 11±50 SAGE tags were detected an average of 65, 85 and 88% of the time, respectively. It should be noted that transcripts with a SAGE tag count of at least 5 in this study are considered reliably detected by SAGE. Figure 1c expands the SAGE tag abundance bins into their relative distributions across detection ef®ciencies by Gene Chips. This ®gure shows what percentage of transcripts from each SAGE tag bin was reliably detected (by 100% of the Gene Chips), undetected (by 0% of the Gene Chips), or detected unreliably (by between 0% and 100% of the Gene Chips). In general, a higher proportion of tags were reliably detected than were undetected or unreliably detected at all expression levels analysed. For transcripts of low abundance, represented by 1±5 SAGE tags, the undetected category was the second largest whereas, for the intermediate-abundance transcripts, represented by 6±50 SAGE tags, the intermediate detection ef®ciency categories were the second largest. Transcripts of high abundance, with > 50 SAGE tags, were never completely undetected by Gene Chips. To summarize, the detection ef®ciency of Gene Chips, in general, increased with the SAGE tag count. However, there were a high percentage of transcripts reliably detected by Gene Chips at all expression levels estimated by SAGE.
The glutamate system is known to play a key role in hippocampal function (Kullmann & Asztely, 1998; Bortolotto et al., 1999) , which is exempli®ed by the fact that glutamate receptors were the most frequently observed class of neurotransmitter receptors in the SAGE study (Datson et al., 2001) . To illustrate how an entire system is detected in the context of these broad analysis tools, we focus on the known components of the glutamate system that are found in both the SAGE and Gene Chip data sets. Table 1 highlights these transcripts and reports both their SAGE tag count and their ef®ciency of detection by Gene Chips. This table shows that increased SAGE tag count generally predicts increased Gene Chip detection ef®ciency within this system, as is the case for transcripts in general. Examination of the transcripts listed in the table show that many receptors are expressed at low levels and are outside the range of reliable detection for both techniques, whereas the transporter and synthesis machineries are expressed at higher levels and more reliably detected. Although the detection by SAGE and Gene Chips correlates quite well, there are some differences. For example, metabotropic glutamate receptor 3, kainate receptor subunit ka2 and glutamate transporter GluT are reliably detected by Gene Chips but not reliably detected by SAGE (< 5 tags) whereas NMDAR1 is reliably detected by SAGE (> 5 tags) but not reliably detected by Gene Chips.
Discussion
In this study we evaluated the sensitivity of Affymetrix Gene Chips in a complex neuronal tissue, the hippocampus. These studies show that relatively high-abundance transcripts are reliably detected by Gene Chips but that a signi®cant percentage of low-abundance transcripts are undetected or unreliably detected. In addition, a vast majority of expressed transcripts in the hippocampus fall into the low-abundance category. This work is important because DNA microarray studies are currently being used to provide a global view of the transcriptome and the current study estimates the degree to which this approach is successful in brain tissue.
Although there is a strong correlation between the expression level of a transcript predicted by SAGE and the detectability of the transcript by Affymetrix Gene Chips the relationship is not strict. The data show that Gene Chip probes complementary to transcripts expressed at similar estimated expression levels do not necessarily perform equally. Gene Chips may under-perform due to probe design issues, such as: distance of the target sequence from the poly-A tail; secondary structures within the target sequence; and cross-reactivity of the probe with other transcripts, each of which may in¯uence detection. On the other hand, SAGE may under-perform because speci®c transcripts may be missed due to the absence of a recognition site for the anchoring enzyme or GC-content bias (Margulies et al., 2001) . In addition, incorrect tag counts can arise from incomplete digestion or alternative polyadenylation, giving rise to multiple tags derived from a single transcript. Also, sequencing errors, especially in the population of tags encountered only once, can contribute to the differences between SAGE and Gene Chip data.
Besides technical explanations, a biological explanation for observed differences between Gene Chip and SAGE data might be that male Wistar rats were used in the SAGE study and male SpragueEvaluation of Affymetrix gene chip sensitivity 411
Dawley rats were used in the Gene Chip studies. Although this may have a small impact on the conclusions drawn below, it is unlikely that it will be signi®cant because these two strains of rats are closely related, as is evident by the overall good correlation in this study between the SAGE and Gene Chip data sets. Supporting an assumption of minimal strain differences, a study using Gene Chips to examine brain expression pro®les of two different strains of mice found < 1% of the genes investigated to be differentially expressed in the hippocampus (Sandberg et al., 2000) .
The SAGE data from rat hippocampus (Datson et al., 2001 ) utilized by the current study is probably not a complete representation of the hippocampal transcriptome. In fact, extrapolating the raw data of unique tags identi®ed vs. tags analysed predicts that there are » 66 000 unique sequence tags (R 2 = 0.998) expressed by hippocampus (data not shown). By these calculations the SAGE study under discussion, which revealed 28 803 unique tags, detected » 41% of the rat hippocampal transcriptome. Thus, calculations relating to the percentage of transcripts detected by Affymetrix Gene Chips as reported in the results section are likely to be overestimates when considering the entire hippocampal transcriptome, because it is probable that the remaining transcripts undetected in the SAGE analysis would be skewed toward the low-abundance bins. Following this logic, it is likely that a large percentage of the transcripts that remain undetected by the SAGE study would also go undetected by Gene Chips. If we assume that the transcripts undetected by SAGE would be detected by Gene Chips no better than those transcripts represented by a single SAGE tag, we can estimate that Affymetrix Gene Chips reliably detect no more than 30% and fail to detect at least 30% of hippocampal-expressed transcripts using a gross hippocampal dissection as the source tissue. This leaves » 40% of hippocampal transcripts falling into the range of unreliable detection.
This study suggests that Affymetrix DNA microarray technology applied to neuroscience can only reliably reveal regulation of mRNA species of medium to high abundance. This shortcoming applies to SAGE as well, given that the overall sensitivity of the two technologies in this study appeared similar.
The consequences of these limitations will obviously depend on the system under investigation. For example, receptors are generally expressed at lower levels than neurotransmitter/neuropeptide processing machinery, as exempli®ed by the glutamate system in this report. Although there will be many exceptions to this, the consequences are that receptor regulation may be more dif®cult to detect by DNA microarrays than regulation of the more abundant synthesis or signal transduction machinery. However, a small number of insights into system regulation generated by DNA microarrays can lead to further discoveries within speci®c pathways by classical studies, such as in situ hybridization or immunocytochemistry.
To conclude, current DNA microarray technology is not likely to reveal regulation of low-abundance transcripts, which represent a large percentage of the transcriptome in complex tissue. However, provided that the limits of Gene Chips are understood, the technology does provide a powerful, state-of-the-art tool to analyse brain transcriptional pro®les and can successfully lead to important discoveries by more focused studies of speci®c systems using other techniques. The table highlights the components of the glutamate system that were uniquely detected by SAGE and represented on Affymetrix RG-U34A gene chips. The SAGE tag count and the detection ef®ciency by gene chips is reported.
